trial

An Open-Label, Single Arm Study of the Efficacy of Accelerated Intermittent Theta Burst Stimulation in Schizophrenia Patients With Persistent Negative Symptoms

NCTId NCT06351514
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 3 · Recruiting
Enrollment 40 (estimated)
Sponsored by Institute of Mental Health, Singapore
Primary completion 2026-09
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 3
Status
Recruiting
Enrollment
40 (estimated)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2024-04-01
Primary completion
2026-09
Eligibility
ALL · 21 Years · 65 Years

Interventions & indications

Drugs
Accelerated iTBS

Sponsors

Institute of Mental Health, SingaporeLead Sponsor

Sites

1 total
Singapore, Singapore

Linked catalysts

1
An Open-Label, Single Arm Study of the Efficacy of Accelerated Intermittent Thet — primary completion2026-09

Facts & assertions

4 sourced
Enrollment
40
Phase
PHASE3
Primary Completion Date
2026-09
Status
RECRUITING
relationships
The graph out of here
drug
Accelerated iTBS
drug
lead_sponsor
Institute of Mental Health, Singapore
company
indication
Schizophrenia
indication
Schizophrenia; Negative Type
indication